Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
India Becoming Locus of Pharma Outsourcing, RNCOS Predicts 34% Growth
Oct 27, 2008
According to our research report, “Indian Healthcare - New Avenues for Growth”, India, driven by factors such as low cost, availability of a large and skilled workforce and improving health infrastructure, is likely to emerge as the global hub for pharma outsourcing.
According to the report, India’s pharma outsourcing market was worth around US$ 1.3 Billion in 2007, accounting for around 3% of the total healthcare market in India. The industry is expected to grow at a robust CAGR of 34% to 2012, with contract manufacturing and clinical trials accounting for a major share of this market. This huge potential market is attracting international CROs and CRMs to India to set their bases and gain a share in the market.
The research thoroughly investigates the factors which are drawing the global CROs and CRMs to India, and cites that low cost and time of research and manufacturing are India’s biggest strengths. We believe that MNCs can have a substantial cost savings on plant set up, staff and running costs, if they set-up their R&D and manufacturing sites in India. In fact, a number of multinational pharma majors already present in India such as GlaxoSmithKline & Pfizer have started leveraging the country’s comparative advantages in the areas of clinical trial and manufacturing.
With multiple advantages India offers, we expect that the country’s pharma outsourcing market will increase several fold in coming years with western pharma/biotech companies likely to outsource a major pie of their research and manufacturing work to Indian companies.
“Indian Healthcare - New Avenues for Growth” contains unique market-based research and provides rich data and objective analysis on the booming Indian healthcare market. It presents comprehensive statistical and analytical overview on the healthcare market of the country, and provides past, present and future data on the entire structure, composition and working of the Indian healthcare market. The research extensively discusses the opportunities and challenges that are expected to arise within and from the healthcare market. It also provides future forecast on the market to give clients an incisive outlook of the market.
For more information visit: http://www.rncos.com/Report/IM151.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Green Go to Derma Clinical Trial - How will it Shape Industry?
- Liquid Biopsy Paving the Way to Growth through Strategic Transactions
- India- A Largely Untapped Market for NIPT
- Government Initiatives Promoting the Indian Healthcare Sector
- Clinical Chemistry Testing Major Driver for US Clinical Laboratory Testing Market
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact